US2017326192A1PendingUtilityA1

Molecular and Herbal Combinations for Treating Psoriasis

68
Assignee: SIRBAL LTDPriority: Nov 13, 2010Filed: May 29, 2017Published: Nov 16, 2017
Est. expiryNov 13, 2030(~4.3 yrs left)· nominal 20-yr term from priority
Inventors:Nadav Shraibom
A61K 36/355A61K 9/0019A61K 36/185A61K 36/708A61K 36/64A61K 36/73A61K 36/804A61K 36/815A61K 36/65
68
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A treatment regimen for psoriasis includes administering to a patient diagnosed with psoriasis periodic doses of a combination including Sheng Di Huang, Da Huang and Jin Yin Hua, or a combination of the above with Mu Dan Pi, Di Gu Pi, Xian He Cao and Chun Gen Pi.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising administering to a patient diagnosed with leukemia, lymphoma or breast cancer, or combinations thereof, a dosage composition comprising a combination of Sheng Di Huang, Da Huang and Jin Yin Hua;
 wherein said dosage composition comprises between 18% and 90% of said Sheng Di Huang, between 4% and 64% of said Da Huang, and between 4% and 64% of said Jin Yin Hua,   wherein said dosage composition comprises at least 60 wt. % of said combination.   
     
     
         2 . The method of  claim 1 , comprising administering said dosage composition to a patient diagnosed with chronic lymphocytic leukemia (CLL). 
     
     
         3 . The method of  claim 1 , comprising administering said dosage composition to a patient diagnosed with acute milo leukemia (AML). 
     
     
         4 . The method of  claim 1 , comprising administering the dosage composition orally. 
     
     
         5 . The method of  claim 1 , comprising administering the dosage composition subcutaneously. 
     
     
         6 . The method of  claim 1 , comprising administering the dosage composition intravenously. 
     
     
         7 . The method of  claim 1 , wherein the combination comprises at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua. 
     
     
         8 . The method of  claim 7 , wherein the combination comprises between 13.3-60 grams of the Sheng Di Huang, between 3.3-40 grams of the Da Huang, and between 3.3-30 grams of the Jin Yin Hua. 
     
     
         9 . The method of  claim 8 , wherein the combination comprises at least 25 grams of the Sheng Di Huang, at least 10 grams of the Da Huang, and at least 10 grams of the Jin Yin Hua. 
     
     
         10 . A method of treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising administering to a patient diagnosed with leukemia, lymphoma or breast cancer, or combinations thereof, a treatment regimen comprising multiple dosage compositions comprising a combination of Sheng Di Huang, Da Huang and Jin Yin Hua;
 wherein said multiple dosage compositions comprise between 18% and 90% of said Sheng Di Huang, between 4% and 64% of said Da Huang, and between 4% and 64% of said Jin Yin Hua,   wherein said multiple dosage compositions comprise at least 60 wt. % of said combination.   
     
     
         11 . The method of  claim 10 , comprising administering said treatment regimen to a patient diagnosed with chronic lymphocytic leukemia (CLL). 
     
     
         12 . The method of  claim 10 , comprising administering said treatment regimen to a patient diagnosed with acute milo leukemia (AML). 
     
     
         13 . The method of  claim 10 , comprising administering the multiple dosage compositions orally. 
     
     
         14 . The method of  claim 10 , comprising administering the multiple dosage compositions subcutaneously. 
     
     
         15 . The method of  claim 10 , comprising administering the multiple dosage compositions intravenously. 
     
     
         16 . The method of  claim 10 , wherein the regimen comprises at least 13.3 grams of the Sheng Di Huang, at least 3.3 grams of the Da Huang, and at least 3.3 grams of the Jin Yin Hua. 
     
     
         17 . The method of  claim 16 , wherein the regimen comprises between 13.3-60 grams of the Sheng Di Huang, between 3.3-40 grams of the Da Huang, and between 3.3-30 grams of the Jin Yin Hua. 
     
     
         18 . The method of  claim 17 , wherein the regimen comprises at least 25 grams of the Sheng Di Huang, at least 10 grams of the Da Huang, and at least 10 grams of the Jin Yin Hua. 
     
     
         19 . A method of treating leukemia, lymphoma or breast cancer, or combinations thereof, comprising administering to a patient diagnosed with leukemia, lymphoma or breast cancer, or combinations thereof, a treatment regimen comprising multiple dosage compositions comprising a combination of Sheng Di Huang and Da Huang;
 wherein said multiple dosage compositions comprise between 18% and 90% of said Sheng Di Huang, and between 4% and 64% of said Da Huang,   wherein said multiple dosage compositions comprise at least 60 wt. % of said combination.   
     
     
         20 . The method of  claim 19 , wherein the combination comprises between 13.3-60 grams of the Sheng Di Huang, and between 3.3-40 grams of the Da Huang.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.